NextGel (NXGL) is presented as a high-growth, under-appreciated stock with a dual business model and a recent transformative acquisition poised to triple revenue and achieve profitability.
Source Post
One Healthcare Stock With Massive Growth | Nexgel NASDAQ: NXGL
Mar 15, 2026
The creator discusses NextGel (NXGL), a hybrid company in specialized medical manufacturing and consumer goods, highlighting its proprietary hydrogel technology for healthcare and beauty. The video emphasizes NXGL's dual business model (contract manufacturing and branded consumer goods), recent acquisitions like Silly George, and a transformative licensing agreement expected to triple revenue and lead to profitability. The creator believes the stock is undervalued given its growth prospects and operational scalability.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
NXGLbuy opened Mar 15, 2026
-47.17%